Overview

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)

Status:
Recruiting

Trial end date:
2023-06-30

Target enrollment:

Participant gender:

Summary

The main goal of this trial is to inform about long-term safety and tolerability of eptinezumab in participants with chronic cluster headache.

Phase:

Phase 3

Details

Lead Sponsor:

H. Lundbeck A/S